International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology


star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

980.00p

Buy

992.00p

arrow-up16.00p (+1.64%)

Discount/Premium

-6.00%

Estimated NAV

1,053.228p

Prices updated at 12 Dec 2025, 16:43 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

arrow-down-0.48%
LSE

Annual charges

Product charges
1.30
1.50
0.06
Minimum investment25.00

Documents

LanguageDate posted
FactsheetEnglish31 Oct 2025
Key Information Document (KID)English16 Sep 2025
Annual ReportEnglish31 Aug 2025
Semi-Annual ReportEnglish28 Feb 2025
KIIDEnglish12 Jul 2019
Please note that service charges will also apply. Read more about our fees.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.